EVMN
NYSE · Biotechnology
Evommune Inc
$9.65
+0.28 (+2.99%)
Open$9.39
Previous Close$9.37
Day High$9.75
Day Low$9.20
52W High$33.20
52W Low$9.30
Volume—
Avg Volume899.2K
Market Cap342.96M
P/E Ratio—
EPS$-3.83
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+685.5% upside
Current
$9.65
$9.65
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.06M | 78.02M | 75.69M |
| Net Income | -74,504,422 | -16,723,517 | -20,379,208 |
| Profit Margin | -529.8% | -21.4% | -26.9% |
| EBITDA | -86,202,173 | -28,105,243 | -27,281,553 |
| Free Cash Flow | — | -11,355,754 | -12,035,038 |
| Rev Growth | — | -7.7% | +21.3% |
| Debt/Equity | 0.00 | 0.34 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |